To our knowledge, this series showed, for the first time in Switzerland, that Hp(+) individuals exhibit significantly more frequently certain MetS parameters with concomitant premalignant histological lesions including GA and IM without dysplasia, compared to their Hp(−) counterparts. The gene discussed is HP; the disease is metabolic syndrome.